Men’s Health reports that the FDA is considering removing part of a list of 19 synthetic peptides from its Category 2 Bulk Substances List, a move linked to safety concerns. The review is set to look at seven synthetic peptides in July 2026, with another five due in 2027. The guide also explains that peptides are short chains of amino acids, while the synthetic versions are usually delivered by spray or injection. A Stony Brook Medicine expert, …
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.